Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases. - Wikidata - wikimedia - TriplyDB

Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases.

Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases.

http://www.wikidata.org/entity/Q34588717

about

Fenretinide metabolism in humans and mice: utilizing pharmacological modulation of its metabolic pathway to increase systemic exposure Evaluation of a mucoadhesive fenretinide patch for local intraoral delivery: a strategy to reintroduce fenretinide for oral cancer chemoprevention First-pass metabolism via UDP-glucuronosyltransferase: a barrier to oral bioavailability of phenolics.Role of Cytochrome P450 2C8 in Drug Metabolism and Interactions.P450 inhibitor ketoconazole increased the intratumor drug levels and antitumor activity of fenretinide in human neuroblastoma xenograft models.Analysis of fenretinide and its metabolites in human plasma by liquid chromatography-tandem mass spectrometry and its application to clinical pharmacokinetics.

P2860

Q35130547-EEC6CDC5-2D40-41AD-B675-D4FBD3351AD8 Q35907443-49038387-7F8D-45C1-B601-B03BF85082F8 Q36132293-63097B8A-4AC4-46BD-8419-CE52D6242242 Q38684505-A77006B2-B115-4F11-A74E-465122C60B3A Q38710659-1D9A9B53-1CEC-49A2-8F93-5E1623D2A942 Q50283738-885D23E7-6E37-460E-A473-3A64118603AA

P2860

Characterization of the metabolism of fenretinide by human liver microsomes, cytochrome P450 enzymes and UDP-glucuronosyltransferases.

http://www.wikidata.org/entity/Q34588717

description

2011 nî lūn-bûn

@nan

2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Characterization of the metabo ...... UDP-glucuronosyltransferases.

@ast

Characterization of the metabo ...... UDP-glucuronosyltransferases.

@en

Characterization of the metabo ...... UDP-glucuronosyltransferases.

@nl

type

label

Characterization of the metabo ...... UDP-glucuronosyltransferases.

@ast

Characterization of the metabo ...... UDP-glucuronosyltransferases.

@en

Characterization of the metabo ...... UDP-glucuronosyltransferases.

@nl

prefLabel

Characterization of the metabo ...... UDP-glucuronosyltransferases.

@ast

Characterization of the metabo ...... UDP-glucuronosyltransferases.

@en

Characterization of the metabo ...... UDP-glucuronosyltransferases.

@nl

P1433

Q34588717-55C0F227-81A8-4E33-827B-1F0A1CDBFED4

P1476

Q34588717-6E437E30-360A-4980-9CE7-AED9DC883E70

P2093

Q34588717-92C9F447-4B91-4BA4-8047-344EE052BA12

Q34588717-D0C3D3E0-D167-4BC5-94BD-C0047753D731

Q34588717-E6E10527-5B38-4285-9A5C-FF604E85D35B

Q34588717-EC075623-0E2D-40E3-A2F2-67DDC75FA71A

P2860

Q34588717-001D94F9-723A-4CC7-A5F3-9721973376F5

Q34588717-0FBA3ECE-5DDA-44B3-A804-7A26DBA880E7

Q34588717-13AE59FB-A88F-49D3-A3B1-CBE72575FD7A

Q34588717-1BB9E1F6-4CB3-4405-B68C-921F1275BDEA

Q34588717-1FC7E501-560A-4623-AC95-8EA90773F9CE

Q34588717-2A864F2A-66F4-4C0F-ACA7-16EB8AA1CA3A

Q34588717-31B8CE43-2596-427C-9CA4-44F9D555787C

Q34588717-31C5BF6F-5665-4189-9EE9-74F591B35229

Q34588717-328501E8-8B3B-4196-B94D-9EC09EF3312E

Q34588717-4C558328-7FCF-4800-9468-D2AF388A0003

P304

Q34588717-30726C5F-F519-42CC-A584-16501B73A6CF

P31

Q34588717-B1727B2D-5839-482D-8F47-85E712350FAE

P356

Q34588717-B7A5C15F-334D-4A40-9695-DDDFD1EFBB36

P407

Q34588717-B9D17BF5-F14C-40B1-83AB-72F415D3BFF9

P433

Q34588717-AFD82A72-5AB2-47B7-9D26-6718C1D32660

P478

Q34588717-49D1C361-59B3-4F80-A885-7264385CAF91

P577

Q34588717-7795AB2A-3925-4E07-8F9E-414081972875

P5875

Q34588717-6D1717E5-B4A5-4616-B51F-9959887744D2

P698

Q34588717-7A813718-BFA7-4475-B3DC-A355AC58E934

P932

Q34588717-078F2E76-7156-48F3-A74F-738234491AA6

P356

J.1476-5381.2010.01104.X

P1433

British Journal of Pharmacology

P1476

Characterization of the metabo ...... UDP-glucuronosyltransferases.

@en

P2093

A K Daly

http://www.w3.org/2001/XMLSchema#string

A V Boddy

http://www.w3.org/2001/XMLSchema#string

G J Veal

http://www.w3.org/2001/XMLSchema#string

N A Illingworth

http://www.w3.org/2001/XMLSchema#string

P2860

Role of UDP-glucuronosyltransferase isoforms in 13-cis retinoic acid metabolism in humans

Identification of human cytochrome P450s involved in the formation of all-trans-retinoic acid principal metabolites

Identification of human cytochrome P450 isoforms that contribute to all-trans-retinoic acid 4-hydroxylation

The sensitivity of the Ewing's sarcoma family of tumours to fenretinide-induced cell death is increased by EWS-Fli1-dependent modulation of p38(MAPK) activity

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations

Amine N-methyltransferases from rabbit liver

4-hydroxyretinoic acid, a novel substrate for human liver microsomal UDP-glucuronosyltransferase(s) and recombinant UGT2B7

Glucuronidation of estrogens and retinoic acid and expression of UDP-glucuronosyltransferase 2B7 in human intestinal mucosa.

Comparison of inhibitory effects of the proton pump-inhibiting drugs omeprazole, esomeprazole, lansoprazole, pantoprazole, and rabeprazole on human cytochrome P450 activities.

The xenobiotic inhibitor profile of cytochrome P4502C8.

P304

989-999

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1476-5381.2010.01104.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P577

2011-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

224882129

http://www.w3.org/2001/XMLSchema#string

P698

21054342

http://www.w3.org/2001/XMLSchema#string

P932

3042207

http://www.w3.org/2001/XMLSchema#string